Latest California Healthline Stories
Some public health officials fear that the Trump administration’s proposals to change how Title X funding is handled may impede the effort to cut the record number of sexually transmitted diseases.
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
Among changes by the Trump administration, new rules protect consumers living in areas with only one marketplace plan as well as those who oppose abortion and can’t find a plan that doesn’t cover the procedure. These rules will resonate in California, where most health plans are required to cover abortion and six counties have only one insurer selling through the ACA exchange.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post discuss the Trump administration’s latest effort to revise rules for next year’s Affordable Care Act marketplaces. They also discuss state efforts to stabilize their individual markets in light of some of the changes being made at the federal level.
An abortion drug invented decades ago is being used to treat Cushing’s syndrome — and it’s bringing in tens of millions of dollars a year.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Medicaid family planning programs reduce unplanned births, but some are caught in disputes over federal funding to Planned Parenthood.
As Congress considers a bipartisan bill to help hold down premium prices on the health law’s marketplaces, a long-standing fight over abortion reappears.